Latest News and Press Releases

– VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically meaningful improvement in progression-free survival – –...

TMGI subsidiary Music of Your Life launches syndicated radio program as company continues focuse on cancer awareness.

NEW HAVEN, Conn., March 04, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer Liquid Biopsy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...

New York, United States, March 04, 2025 (GLOBE NEWSWIRE) -- Breast cancer is the prevailing ailment in the population, predominantly affecting women who are witnessing an increase in disease...

Myriad Genetics announced a collaboration with Gabbi to provide an integrated offering for breast cancer risk assessment.

New York, USA, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Breast Cancer Market Sees Rapid Growth — Key Insights and Forecasts of Different Breast Cancers for the Coming 10 Years | DelveInsight The breast...

Plus Therapeutics Advances Lead Drug Rhenium (186Re) Obisbemeda for Patients with Leptomeningeal Metastases

– Announced that topline data from the monotherapy Phase 3 VERITAC-2 trial is anticipated in 1Q25 – – Presented Phase 1b data from the TACTIVE-U sub-study of vepdegestrant in...

The new study adds to growing evidence that measuring activated proteins is key to cancer therapy selection. Golden, CO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of...